(DDS) Dillard's - Ratings and Ratios
Apparel, Accessories, Cosmetics, Home Furnishings, Footwear
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.63% |
| Yield on Cost 5y | 6.22% |
| Yield CAGR 5y | 18.64% |
| Payout Consistency | 93.2% |
| Payout Ratio | 84.4% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 43.9% |
| Value at Risk 5%th | 63.7% |
| Relative Tail Risk | -11.90% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.07 |
| Alpha | 40.67 |
| CAGR/Max DD | 0.71 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.419 |
| Beta | 1.097 |
| Beta Downside | 0.805 |
| Drawdowns 3y | |
|---|---|
| Max DD | 42.02% |
| Mean DD | 14.05% |
| Median DD | 13.26% |
Description: DDS Dillard's January 09, 2026
Dillards, Inc. (NYSE: DDS) is a publicly traded department-store operator headquartered in Little Rock, Arkansas. It runs a network of brick-and-mortar locations across the Southeast, Southwest and Midwest, complemented by an e-commerce platform (dillards.com) and clearance centers. The merchandise mix includes apparel for men, women and children, accessories, cosmetics, home furnishings and other consumer goods. In addition to retail, the company performs its own store construction and remodeling activities.
Key recent metrics (as of FY 2024 Q4): same-store sales rose 3.2% year-over-year, driven primarily by a 5% increase in women’s apparel; net sales reached $4.1 billion, and operating margin improved to 5.8% after cost-saving initiatives. The balance sheet shows total debt of $1.2 billion with a debt-to-EBITDA ratio of 2.1×, indicating moderate leverage. The company’s e-commerce share of total sales is now ~12%, reflecting a gradual shift toward omni-channel fulfillment.
Economic and sector drivers that materially affect DDS include: (1) consumer discretionary spending trends, which are sensitive to employment growth and real-wage inflation; (2) inflationary pressure on apparel and home-goods input costs, influencing pricing power and margins; and (3) competitive dynamics in the broadline retail space, where consolidation and the rise of fast-fashion and pure-play online retailers pressure traditional department-store market share.
For a deeper quantitative dive into Dillard’s valuation assumptions and scenario analysis, you might find the ValueRay platform’s research tools useful.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (580.9m TTM) > 0 and > 6% of Revenue (6% = 397.5m TTM) |
| FCFTA 0.18 (>2.0%) and ΔFCFTA 1.93pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 26.01% (prev 25.47%; Δ 0.55pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.20 (>3.0%) and CFO 867.2m > Net Income 580.9m (YES >=105%, WARN >=100%) |
| Net Debt (-600.6m) to EBITDA (926.7m) ratio: -0.65 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.19 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (15.6m) change vs 12m ago -3.11% (target <= -2.0% for YES) |
| Gross Margin 38.88% (prev 40.96%; Δ -2.09pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 157.2% (prev 162.0%; Δ -4.88pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -517.6 (EBITDA TTM 926.7m / Interest Expense TTM -1.45m) >= 6 (WARN >= 3) |
Altman Z'' 11.87
| (A) 0.40 = (Total Current Assets 3.17b - Total Current Liabilities 1.45b) / Total Assets 4.30b |
| (B) 1.53 = Retained Earnings (Balance) 6.58b / Total Assets 4.30b |
| warn (B) unusual magnitude: 1.53 — check mapping/units |
| (C) 0.18 = EBIT TTM 751.1m / Avg Total Assets 4.22b |
| (D) 2.90 = Book Value of Equity 6.54b / Total Liabilities 2.25b |
| Total Rating: 11.87 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 72.59
| 1. Piotroski 6.0pt |
| 2. FCF Yield 7.96% |
| 3. FCF Margin 11.74% |
| 4. Debt/Equity 0.27 |
| 5. Debt/Ebitda -0.65 |
| 6. ROIC - WACC (= 14.36)% |
| 7. RoE 30.50% |
| 8. Rev. Trend -35.32% |
| 9. EPS Trend -52.84% |
What is the price of DDS shares?
Over the past week, the price has changed by -2.89%, over one month by +11.04%, over three months by +19.52% and over the past year by +47.04%.
Is DDS a buy, sell or hold?
- Strong Buy: 0
- Buy: 0
- Hold: 1
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the DDS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 561.3 | -17.5% |
| Analysts Target Price | 561.3 | -17.5% |
| ValueRay Target Price | 888.4 | 30.6% |
DDS Fundamental Data Overview January 18, 2026
P/E Forward = 35.7143
P/S = 1.5666
P/B = 5.0754
P/EG = -1.28
Revenue TTM = 6.63b USD
EBIT TTM = 751.1m USD
EBITDA TTM = 926.7m USD
Long Term Debt = 425.7m USD (from longTermDebt, last quarter)
Short Term Debt = 106.0m USD (from shortTermDebt, last quarter)
Debt = 548.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -600.6m USD (from netDebt column, last quarter)
Enterprise Value = 9.78b USD (10.38b + Debt 548.6m - CCE 1.15b)
Interest Coverage Ratio = -517.6 (Ebit TTM 751.1m / Interest Expense TTM -1.45m)
EV/FCF = 12.57x (Enterprise Value 9.78b / FCF TTM 778.0m)
FCF Yield = 7.96% (FCF TTM 778.0m / Enterprise Value 9.78b)
FCF Margin = 11.74% (FCF TTM 778.0m / Revenue TTM 6.63b)
Net Margin = 8.77% (Net Income TTM 580.9m / Revenue TTM 6.63b)
Gross Margin = 38.88% ((Revenue TTM 6.63b - Cost of Revenue TTM 4.05b) / Revenue TTM)
Gross Margin QoQ = 41.24% (prev 34.64%)
Tobins Q-Ratio = 2.28 (Enterprise Value 9.78b / Total Assets 4.30b)
Interest Expense / Debt = -0.42% (Interest Expense -2.30m / Debt 548.6m)
Taxrate = 23.10% (39.0m / 168.8m)
NOPAT = 577.5m (EBIT 751.1m * (1 - 23.10%))
Current Ratio = 2.19 (Total Current Assets 3.17b / Total Current Liabilities 1.45b)
Debt / Equity = 0.27 (Debt 548.6m / totalStockholderEquity, last quarter 2.05b)
Debt / EBITDA = -0.65 (Net Debt -600.6m / EBITDA 926.7m)
Debt / FCF = -0.77 (Net Debt -600.6m / FCF TTM 778.0m)
Total Stockholder Equity = 1.90b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.78% (Net Income 580.9m / Total Assets 4.30b)
RoE = 30.50% (Net Income TTM 580.9m / Total Stockholder Equity 1.90b)
RoCE = 32.23% (EBIT 751.1m / Capital Employed (Equity 1.90b + L.T.Debt 425.7m))
RoIC = 23.81% (NOPAT 577.5m / Invested Capital 2.43b)
WACC = 9.44% (E(10.38b)/V(10.93b) * Re(9.96%) + D(548.6m)/V(10.93b) * Rd(-0.42%) * (1-Tc(0.23)))
Discount Rate = 9.96% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.40%
[DCF Debug] Terminal Value 71.24% ; FCFF base≈734.2m ; Y1≈667.1m ; Y5≈583.1m
Fair Price DCF = 756.6 (EV 8.20b - Net Debt -600.6m = Equity 8.80b / Shares 11.6m; r=9.44% [WACC]; 5y FCF grow -11.38% → 2.90% )
EPS Correlation: -52.84 | EPS CAGR: -16.91% | SUE: 1.19 | # QB: 1
Revenue Correlation: -35.32 | Revenue CAGR: -9.34% | SUE: 1.69 | # QB: 1
EPS next Quarter (2026-04-30): EPS=9.24 | Chg30d=-0.040 | Revisions Net=+1 | Analysts=1
EPS next Year (2027-01-31): EPS=27.92 | Chg30d=+2.330 | Revisions Net=+1 | Growth EPS=-14.1% | Growth Revenue=+1.0%
Additional Sources for DDS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle